Back to Search
Start Over
The effect of daily fortified yogurt consumption on weight loss in adults with metabolic syndrome: A 10-week randomized controlled trial.
- Source :
-
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2018 Jun; Vol. 28 (6), pp. 565-574. Date of Electronic Publication: 2018 Mar 10. - Publication Year :
- 2018
-
Abstract
- Background and Aims: Obesity is a complex and multifaceted condition. Thus, functional foods need investigation as novel adjunct treatments for obesity. The objective was to determine the effects of daily consumption of a fortified yogurt (FY) on weight loss in overweight and obese patients with metabolic syndrome on a caloric-restricted diet.<br />Methods and Results: This was a randomized, double-blind, 10-week study. Participants were randomly allocated to two groups receiving either two servings (2 × 250 g)/day of FY with whey protein, calcium, vitamin D, prebiotic fibre and probiotic cultures (n = 44) or a low-fat plain yogurt (PY) (n = 43). All participants were put on a calorie-restricted diet throughout the 10-week study. Body composition and biochemical indices were assessed before and after the intervention. Body mass decreased by 4.3 ± 1.9 kg and 5.1 ± 3.0 kg in the PY and FY groups, respectively, following the 10-week intervention. Compared to PY, consumption of FY resulted in a significant reduction in body fat mass (FM) (p = 0.023), body fat percentage (p = 0.028), waist circumference (p = 0.002), homoeostasis model of assessment-insulin resistance (HOMA-IR) (p = 0.025), triglyceride concentration (p = 0.003), and a significant increase in total 25-hydroxyvitamin D (25(OH)D) concentration (p < 0.001), high density lipoprotein-cholesterol (HDL-C) (p = 0.009) and quantitative insulin sensitivity check index (QUICKI) (0.022). Participants consuming the FY lost less fat-free mass (FFM) compared to the PY group (Δ = -0.9 ± 3.5 kg vs. Δ = -2.0 ± 2.7 kg; p = 0.025).<br />Conclusions: Consuming FY for 10-weeks improved body composition and metabolic parameters, while on a caloric-restricted diet. Further research is needed to elucidate whether FY can be used as a preventative strategy for metabolic syndrome in obese persons.<br />Trial Registration: www.irct.ir (IRCT2017050633836N1).<br /> (Copyright © 2018. Published by Elsevier B.V.)
- Subjects :
- Adiposity
Adult
Aged
Calcium administration & dosage
Double-Blind Method
Female
Humans
Iran
Male
Metabolic Syndrome diagnosis
Metabolic Syndrome microbiology
Metabolic Syndrome physiopathology
Middle Aged
Obesity diagnosis
Obesity microbiology
Obesity physiopathology
Portion Size
Prebiotics administration & dosage
Probiotics administration & dosage
Recommended Dietary Allowances
Time Factors
Treatment Outcome
Vitamin D administration & dosage
Whey Proteins administration & dosage
Young Adult
Caloric Restriction
Food, Fortified microbiology
Metabolic Syndrome diet therapy
Obesity diet therapy
Weight Loss
Yogurt microbiology
Subjects
Details
- Language :
- English
- ISSN :
- 1590-3729
- Volume :
- 28
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Nutrition, metabolism, and cardiovascular diseases : NMCD
- Publication Type :
- Academic Journal
- Accession number :
- 29724529
- Full Text :
- https://doi.org/10.1016/j.numecd.2018.03.001